SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s00296-021-04792-9.pdf
Reference63 articles.
1. Lambert H, Gupte J, Fletcher H, Hammond L, Lowe N, Pelling M et al (2020) COVID-19 as a global challenge: towards an inclusive and sustainable future. Lancet Planet Health 4(8):e312-314
2. Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, Pinior B, Thurner S, Klimek P (2020) Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav 4(12):1303–1312
3. Gasparyan AY, Misra DP, Yessirkepov M, Zimba O (2020) Perspectives of immune therapy in Coronavirus disease 2019. J Korean Med Sci 35(18):e176
4. Georgiev T, Angelov AK (2020) Complexities of diagnosis and management of COVID-19 in autoimmune diseases: potential benefits and detriments of immunosuppression. World J Clin Cases 8(17):3669–3678
5. Fontanet A, Cauchemez S (2020) COVID-19 herd immunity: where are we? Nat Rev Immunol 20(10):583–584
Cited by 129 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stealth mRNA nanovaccines to control lymph node trafficking;Journal of Controlled Release;2024-10
2. Reactive Arthritis Following COVID-19 Vaccination: Report of Three Cases;Aktuelle Rheumatologie;2024-07-10
3. Design, Synthesis, and Biological Evaluation of 1,2,4-Oxadiazole Derivatives Containing an Aryl Carboxylic Acid Moiety as Potent Sarbecovirus Papain-like Protease Inhibitors;Journal of Medicinal Chemistry;2024-06-13
4. Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study;International Journal of Rheumatic Diseases;2024-05
5. Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination;npj Vaccines;2024-04-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3